NCT01672814View on ClinicalTrials.gov

Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus

PHASE3CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

June 1, 2017

Study Completion Date

June 1, 2017

Conditions
Keratoconus
Interventions
DRUG

riboflavin ophthalmic solution

Administration of riboflavin every 2 minutes for 20 minutes

DEVICE

Vedera KXS Microwave System

The Vedera KXS dose will be based on the pre-treatment manifest refraction spherical equivalent (MRSE), to be administered one day prior to the CXL procedure.

Trial Locations (1)

07666

Cornea and Laser Eye Institue - Hersh Vision Group, Teaneck

All Listed Sponsors
lead

Cornea and Laser Eye Institute

OTHER

NCT01672814 - Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus | Biotech Hunter | Biotech Hunter